D&O Insurance for Private Equity Board Directors

Why PE professionals have a different D&O risk profile

When you represent your fund on a portfolio company board, you're acting in at least three overlapping capacities at once: as a director of the portfolio company, as an agent of the GP, and as a fiduciary to your fund's LPs. Each carries distinct legal exposure. A single claim can pierce all three simultaneously.

Typical sources of director liability in a PE portfolio company context:

• Shareholder derivative suits. Management teams, minority equity holders, or creditors allege that the board's decisions (debt load, management changes, dividend recaps) breached the duty of care or loyalty.
• Securities class actions. At IPO or in public markets, securities fraud and disclosure failures name board members personally.
• M&A litigation. Acquirer shareholders or target minority holders challenge deal process, price, or conflict disclosures. This is the most common trigger in PE M&A.
• Creditor litigation in distress. When a portfolio company enters financial difficulty, lenders and trade creditors increasingly sue board members for decisions made in the "zone of insolvency."
• Regulatory enforcement. SEC, DOJ, FTC, or CFPB actions can name directors individually, especially in financial services, healthcare, or heavily regulated industries.

The financial exposure from any of these is uncapped at the director level unless insurance and indemnification pick up the tab. For a PE partner with $5M–$50M of personal net worth, a single uninsured D&O claim that runs to trial can be existential.

What fund-level D&O covers — and what it doesn't

Most PE firms purchase a fund-level D&O policy that covers the GP entity, the fund manager, and professionals in their capacity as employees or representatives of the fund. This policy is designed to protect fund management activities: investment decisions, LP relationships, fund-level regulatory matters.

It typically does not extend to your activities as a director sitting on a portfolio company board. The two coverage environments are legally distinct:

Side A, Side B, and Side C D&O: the structure that matters

D&O policies are divided into three coverage insuring agreements. Understanding the distinction matters because Side A is the only one that protects your personal assets directly.

Side A — Non-indemnified losses (direct personal coverage). This covers the director personally when the company cannot or will not indemnify them — typically because the company is bankrupt, the loss arises from fraud or a conduct exclusion that voids indemnification, or a court enjoins the company from paying. Side A dollars come directly to you, not through the company. This is the protection you need to care about as a PE board director.

Side B — Company reimbursement coverage. Reimburses the portfolio company when it has already advanced defense costs and indemnification payments to a covered director. Protects the company's balance sheet, not yours directly.

Side C — Entity securities coverage. Covers the company's own liability in securities claims where it's a co-defendant. Usually applies only to public companies. Irrelevant for most private-company PE board seats — until the IPO.

Many portfolio company D&O policies are purchased with an aggregate limit shared across all three insuring agreements. A large securities class action can exhaust the entire policy limit — leaving nothing for Side A personal claims. Dedicated Side-A-only (or "Side A Difference in Conditions") policies provide a separate limit that can't be diluted by entity claims.

Indemnification: your first line of defense and its limits

Before insurance pays, you rely on the portfolio company's obligation to indemnify you. Under Delaware General Corporation Law § 145,¹ a corporation may indemnify directors and officers for amounts paid in defense of third-party actions, if the director acted in good faith and in a manner reasonably believed to be in the best interests of the corporation.

For "derivative actions" (suits brought on behalf of the company itself), indemnification is permitted only if a court authorizes it — the corporation can't simply authorize it in its bylaws. This matters in PE because shareholder derivative suits are common in leveraged buyouts and management-dispute contexts.

Three scenarios where indemnification fails you — and Side A matters:

• Portfolio company bankruptcy. The company enters Chapter 11 or Chapter 7. The indemnification obligation becomes an unsecured claim — worthless in practice. Side A fills the gap because it's a direct insurance claim against the carrier, not the debtor.
• Conduct exclusion voids indemnification. A judgment holds that you engaged in fraud, intentional misconduct, or self-dealing. State law in many jurisdictions (including Delaware) prohibits indemnification for conduct adjudged to involve bad faith. The policy's conduct exclusion may also apply — but defense costs prior to a final adverse judgment are often still covered.
• Court injunction. A court order prohibits the company from making indemnification payments while litigation proceeds. Rare, but it occurs in high-profile insolvency and securities cases.

Indemnification agreement review. Before joining any portfolio company board, request and review the company's indemnification agreement template. Standard DGCL language is not always sufficient. Best-practice indemnification agreements include: mandatory (not permissive) indemnification language, advancement of expenses during proceedings (critical for funding your defense while a case is pending), and a requirement that the company maintain D&O insurance at specified minimums. Many PE boards accept whatever the company's standard template says; that's a mistake worth fixing on the front end.

Tail coverage: what happens when you leave the board

D&O insurance is written on a claims-made basis. The policy that responds to a claim is the one in force at the time the claim is made — not the one in force when the underlying events occurred. If the portfolio company's D&O policy lapses, or you leave the board and there's no extended reporting period (tail coverage), you have no protection for acts that occurred during your tenure but are claimed afterward.

Tail events that create this risk:

• Portfolio company is acquired and the new owner cancels or restructures the prior policy
• Fund wind-down — fund-level D&O lapses when the GP entity dissolves
• Firm departure — partner leaves the PE firm, coverage under firm's policy ends
• Portfolio company IPO — public company D&O replaces private company policy; pre-IPO activities may not carry over

Tail coverage (formally, an "extended reporting period endorsement") keeps you covered for claims arising from pre-departure activities, made after your policy terminates. Standard tail periods are 1, 3, or 6 years. Cost is typically 100–200% of the final year's annual premium, paid as a lump sum. For a $10M limit policy running $8,000/year, a 3-year tail runs $8,000–$16,000 — inexpensive relative to defense cost exposure.

Personal umbrella and excess liability: not a substitute for D&O

A common misconception is that a large personal umbrella policy ($5M–$10M) provides protection against director liability. It doesn't. Personal umbrella and excess liability policies universally exclude claims arising from the insured's duties as a director, officer, trustee, or partner of a business entity. The exclusion language is explicit.

This is not a coverage gap you can bridge with a higher umbrella limit. D&O and personal umbrella serve completely different purposes:

• Personal umbrella: protects against automobile liability, personal injury, defamation, and similar personal (non-business) exposures above homeowners and auto policy limits.
• D&O: covers claims arising from corporate governance decisions in your capacity as a director or officer.

PE professionals should have both. A $5M–$10M personal umbrella is appropriate at your net worth level regardless of board exposure. The D&O coverage is an additional, separate layer.

Coverage across multiple board seats

A PE partner serving on 5 portfolio company boards has 5 separate coverage environments. Each portfolio company purchases its own D&O policy; the limits aren't pooled or portable across companies. A claim at Company A uses Company A's policy; Company B's policy is untouched.

This creates two problems:

1. Coverage quality is uneven. You control what the fund buys for the fund-level D&O, but portfolio company D&O is typically procured by the company's management or CFO. Unless the board actively sets minimum D&O standards, coverage at smaller, earlier-stage companies may be inadequate. A PE partner should ask for the D&O policy binder at every company where they sit — it's a fair and routine request.
2. Simultaneous claims across multiple portfolio companies exhaust personal defense bandwidth. Defense costs in multiple simultaneous proceedings can accumulate even when each company's policy has adequate limits, because advancement of expenses is not always immediate and seamless.

D&O coverage review checklist for PE board directors

At the time you join a board:

• ☐ Request the portfolio company's current D&O policy binder. Confirm limits (Side A, B, C separately), claims-made trigger, and any exclusions.
• ☐ Review the company's indemnification agreement. Confirm mandatory (not permissive) advancement of expenses, not just final indemnification.
• ☐ Confirm the company will maintain D&O at agreed minimums through your board tenure and for a tail period after.
• ☐ Understand whether the fund's D&O policy has any contribution to this board seat. If yes, confirm whether it's a separate sublimit or shared with the main limit.
• ☐ Note the policy renewal date. Board directors should be flagged when the portfolio company renews D&O — a 30% rate increase or coverage reduction should prompt a board-level conversation.

Ongoing:

• ☐ Verify renewal at each portfolio company annually. Insurers non-renew distressed or regulatory-troubled companies — the time when you most need coverage is when it's hardest to obtain.
• ☐ If the company is heading toward IPO, confirm the transition to public company D&O and the continuity of pre-IPO acts coverage.
• ☐ If the company is in financial distress, flag the indemnification failure risk proactively and confirm adequate Side A limits are in place.

At departure:

• ☐ Negotiate extended reporting period (tail) coverage for board activities pre-departure. Ideally, 3–6 years. Confirm this in writing before your effective departure date.
• ☐ Confirm tail under fund-level D&O if you're also leaving the firm.
• ☐ Retain copies of all D&O binders and indemnification agreements. These are important post-departure documents.

Sources

1. Delaware General Corporation Law § 145 — Indemnification of officers, directors, employees and agents (mandatory advancement, permissive indemnification, limitations for derivative suits)
2. SEC guidance on director indemnification disclosures
3. Securities Exchange Act § 10(b) and Rule 10b-5 — securities fraud exposure for board directors
4. Insurance Journal — D&O market trends and pricing

Content verified as of June 2026. Delaware corporate law and D&O insurance markets are subject to change; confirm current policy terms with a licensed insurance professional and review indemnification agreements with qualified legal counsel. This is informational, not legal or insurance advice.